Bayer Schering Gets Positive European Review For Zevalin In Follicular Lymphoma
This article was originally published in The Pink Sheet Daily
Executive Summary
CTI anticipates second-half filing in the U.S., CEO Bianco tells “The Pink Sheet” DAILY.